This chapter advances the UN SDG goals 3 and 17 discusses the effects COVID had on the lifestyle of patients with AD.

This chapter advances the UN SDG goals 3 and 17 discusses the female gender on AD risk.

This chapter advances the UN SDG goal 3 and 17 by exploring antiogensin in relation to the treatment of neurological disorders

This content aligns with Goal 3: Good Health and Wellbeing by providing a current understanding of the cellular and molecular basis of mammalian antifungal immunity, which shows promise for guiding immunotherapy and vaccination strategies for at-risk patients, including those with HIV/AIDS.

This chapter aligns with SDGs 3 and 6, by providing applications of geospatial technologies to monitoring water quality.

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information about esophageal squamous cell carcinoma (ESCC) and the upper aerodigestive microbiomes role in carcinogenesis and outcomes.

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on the role of eosinophils in health and disease, including novel therapeutic approaches and their contribution to our understanding of the role that eosinophils play in homeostasis and pathogenesis.

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by advancing understanding of MG pathophysiology to improve current therapies and contribute to the development of novel, MG-specific therapeutics.

This content supports the SDG Goal 3: Good health and well-being by Typical histological findings of autoimmune hepatitis showing marked lymphoplasmacellular infiltration of the portal tract with interface hepatitis. the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.

This content aligns with Goal 3: Good Health and Wellbeing by highlighting the interactions of the Human immunodeficiency virus (HIV)-1 with the immune system.